Chicago Capital LLC 13D/13G Filings for Albireo Pharma, Inc. (ALBO)

Chicago Capital LLC 13D and 13G filings for Albireo Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-01-23
12:49 pm
Purchase		 2022-12-31 13G Albireo Pharma, Inc.
ALBO		 Chicago Capital LLC 1,362,484
6.600%		 390,599increase
(+40.19%)		 Filing
2022-03-07
08:56 am
Purchase		 2022-03-01 13G Albireo Pharma, Inc.
ALBO		 Chicago Capital LLC 971,885
5.100%		 971,885increase
(New Position)		 Filing